Lithium Therapy Market

1
Lithium Therapy Market To Reach USD 128.6 Million
By 2027
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
The growing prevalence of bipolar disorder is a
significant factor influencing market
demand. Market Size USD 103.9 Million in 2018,
Market Growth - CAGR of 2.3, Market Trends
Growing geriatric population The global lithium
therapy market is expected to reach USD 128.6
Million by 2027, according to a new report by
Reports and Data. Lithium Therapy is used as an
antipsychotic drug for treating bipolar disorder.
Sometimes, it may be utilized in other disorders
to supplement an antidepressant that is unable to
treat depression effectively.
3
Our Approach
Market Summary

• The growing prevalence of bipolar disorder is a
  significant factor in influencing the market
  growth. Bipolar disorder is a neurobiological
  disorder of the brain that currently impacts
  nearly 2.3 million people in the U.S. or about
  1.0 of the total U.S. population. Suicide is the
  foremost reason for premature death amongst
  people who have bipolar disorder, with 15.0 to
  17.0 committing suicide, owing to negative
  symptoms that arise from an untreated illness.
  Individuals who have bipolar disorder were over
  25 times more likely to experience panic disorder
  and around ten times more likely to experience
  obsessive-compulsive disorder as compared to
  people in the general population with the
  condition.
• The growing geriatric population is likely to
  boost the market demand in the forecast period.
  According to a study, bipolar disorder exists in
  6.0 of geriatric outpatient appointments,
  8.010.0 of geriatric inpatient admissions,
  3.0 of geriatric people admitted in nursing
  homes, and 17 of geriatric patients referred to
  psychiatric emergency departments. Hence, the
  worldwide rise in the aging population will be
  directly proportional to the number of older
  adults with the condition.
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /2586

4
Our Approach
Market Summary

• Key participants include Pfizer, Alkem, Sun
  Pharma, Apotek Corp., Glenmark Generics, Intas,
  Taurus Labs, GlaxoSmithKline, Noven
  Pharmaceuticals, and Cardinal Health, among
  others.
• For the purpose of this report, Reports and Data
  have segmented the global lithium therapy market
  on the basis of product type, dosage form,
  distribution channel, and region
• Product Type Outlook (Revenue, USD Million
  2016-2027)
• Generic
• Branded
• Dosage Form Outlook (Revenue, USD Million
  2016-2027)
• Capsule
• Solution
• Tablet, Extended Release
• Tablet

5
Our Approach
Market Summary

• Distribution Channel Outlook (Revenue, USD
  Million 2016-2027)
• Hospital Clinic Pharmacies
• Online-Retail Pharmacies
• Offline-Retail Pharmacies
• Regional Outlook (Revenue, USD Million
  2016-2027)
• North America
• Europe
• Asia Pacific
• Latin America
• MEA
• View press release for more information _at_
  https//www.globenewswire.com/news-release/2020/03
  /09/1997330/0/en/Lithium-Therapy-Market-To-Reach-U
  SD-128-6-Million-By-2027-Reports-and-Data.html

6
About Us
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com